Safety and Efficacy of IMCnyeso in Advanced NY-ESO-1 and/or LAGE-1A Positive Cancers

Clinical trial NCT03515551 · TERMINATED

Trial details

NCT number: NCT03515551
Sponsor: Immunocore Ltd
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Select Advanced Solid Tumors

Start date: 2018-06-15
Primary completion: 2021-05-10
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.